Research Article

Low HOXA13 Expression in the Sacrouterine Ligament as A Risk Factor for Grade III-IV Uterine Prolapse

Andianto Indrawan Tjiptohardjo
Prof I. G. N.G. Ngoerah General Hospital, Indonesia
* Corresponding author
I Wayan Megadhana
Prof I. G. N.G. Ngoerah General Hospital, Indonesia
I Gede Mega Putra
Prof I. G. N.G. Ngoerah General Hospital, Indonesia
Ida Bagus Gde Fajar Manuaba
Prof I. G. N.G. Ngoerah General Hospital, Indonesia
Made Bagus Dwi Aryana
Prof I. G. N.G. Ngoerah General Hospital, Indonesia
I Gde Sastra Winata
Prof I. G. N.G. Ngoerah General Hospital, Indonesia
DOI icon 10.24018/ejmed.2023.5.1.1536

Read Counter
636

Downloads
353

Citations

Share

Article Sidebar

Submitted 2022-10-05
Published 2023-02-05

Read counter = 636 times

Table of Contents

Article Main Content

Introduction: Uterine prolapse grade III and IV or advance stage uterine prolapse manifest in symptoms that reduces the quality of life of women. Sacrouterine ligaments are the main support of the uterus in preventing advanced stage uterine prolapse. Remodeling process occurs in the extracellular matrix and there are many genes that are involved in the process. One of the gene that is involved is the HOXA13 that upregulates the components of extracellular matrix. This study focuses on the expression of HOXA13 in the sacrouterine ligament as a risk factor in occurring advanced stage uterine prolapse.

Methods: We designed an unmatched case-control study to include 44 cases of women that was performed hysterectomy in Prof I. G. N. G Ngoerah Hospital. 22 cases are with advanced stage uterine prolapse and the 22 controls are with non-uterine prolapse. Sacrouterine ligaments samples were collected, and immunohistochemistry was performed. Chi-square test was done to find the odds ratio of the low expression of HOXA13 with advanced stage uterine prolapse.

Results: We found 16 (72%) women in this case group had a low HOXA13 expression, while only 5 (22%) women in the control group had a low expression of the gene. Low expression of HOXA13 in sacrouterine ligament has 9 times risk of having advanced stage uterine prolapse (OR = 9.067; 95% CI = 2,3-36.65; p =0,001) compared with the high expression.

Conclusion: Low expression of HOXA13 increases the risk of advanced stage uterine prolapse and subsequently may become a possible predictor for uterine prolapse.

Keywords: HOXA13 pelvic organ prolapse uterine prolapse sacrouterine ligmanet

References

  1. Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women's Health Initiative: Gravity and gravidity. Am J Obstet Gynecol. 2002; 186(6): 1160-11666.
    DOI  |   Google Scholar
  2. Walker GJ, Gunasekera P. Pelvic organ prolapse and incontinence in developing countries: Review of prevalence and risk factors. Int Urogynecol J. 2011; 22(2): 127-135.
    DOI  |   Google Scholar
  3. Kusuma IGYS, Putra IGM, Megadhana IW, Sanjaya INH, Manuaba IF. Characteristic of patients with pelvic organ prolapse in obstetric and gynecologic outpatient clinic in Sanglah Hospital, Bali, Indonesia from January 2014 to December 2015. Bali Med J. 2017; 6(1): 76-81.
    DOI  |   Google Scholar
  4. Theocharis AD, Skandalis SS, Gialeli C, Karamanos NK. Extracellular matrix structure. Adv Drug Deliv Rev. 2016; 97: 4-27.
    DOI  |   Google Scholar
  5. Connell KA, Guess MK, Tate A, Andikyan V, Bercik R, Taylor HS. Diminished vaginal HOXA13 expression in women with pelvic organ prolapse. Menopause. 2009; 16(3): 529.
    DOI  |   Google Scholar
  6. Kim SR, Park S, Moon Y, Bai S. HOXA 11 and 13 expression in women with pelvic floor disorder. Int Urogynecol J. 2014; 25.
     Google Scholar
  7. DeLancey JO, Low LK, Miller JM, Patel DA, Tumbarello JA. Graphic integration of causal factors of pelvic floor disorders: An integrated life span model. Am J Obstet Gynecol. 2008; 199(6): 610-e1.
    DOI  |   Google Scholar
  8. Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, et al. Prevalence and trends of symptomatic pelvic floor disorders in US women. Obstet Gynecol. 2014; 123(1): 141-148.
    DOI  |   Google Scholar
  9. Pratiwi KMY, Putra IGM. Prolaps Organ Panggul. Medicinus. 2019; 7(1): 27.
    DOI  |   Google Scholar
  10. Patel DA, Xu X, Thomason AD, Ransom SB, Ivy JS, DeLancey JO. Childbirth and pelvic floor dysfunction: An epidemiologic approach to the assessment of prevention opportunities at delivery. Am J Obstet Gynecol. 2006; 195(1): 23-28.
    DOI  |   Google Scholar
  11. Dietz HP, Rozsa D, Subramaniam N, Friedman T. Does Vaginal Parity Alter the Association Between Symptoms and Signs of Pelvic Organ Prolapse? J Ultrasound Med. 2021; 40(4): 675-679.
    DOI  |   Google Scholar
  12. Kayembe AT, Kayembe CDKK, Bebele JPK, Tozin RR. Factors associated with genital prolapse to Saint Joseph Hospital of Kinshasa. Pan Afr Med J. 2021; 40.
    DOI  |   Google Scholar
  13. Vergeldt TF, Weemhoff M, IntHout J, Kluivers KB. Risk factors for pelvic organ prolapse and its recurrence: A systematic review. Int Urogynecol J. 2015; 26(11): 1559-1573.
    DOI  |   Google Scholar
  14. Gumanga SK, Munkaila A, Malechi H. Social demographic characteristics of women with pelvic organ prolapse at the Tamale Teaching Hospital, Ghana. Ghana Med J. 2014; 48(4): 208-213.
    DOI  |   Google Scholar
  15. Woodman PJ, Swift SE, O’Boyle AL, Valley MT, Bland DR, Kahn MA, et al. Prevalence of severe pelvic organ prolapse in relation to job description and socioeconomic status: A multicenter cross-sectional study. Int Urogynecol J. 2006; 17(4): 340-345.
    DOI  |   Google Scholar
  16. Dökmeci F, Tekşen F, Çetinkaya ŞE, Özkan T, Kaplan F, Köse K. Expressions of homeobox, collagen and estrogen genes in women with uterine prolapse. Eur J Obstet Gynecol Reprod Biol. 2019; 233: 26-29.
    DOI  |   Google Scholar
  17. Williams TM, Williams ME, Kuick R, Misek D, McDonagh K, Hanash S, et al. Candidate downstream regulated genes of HOX group 13 transcription factors with and without monomeric DNA binding capability. Dev Biol. 2005; 279(2): 462-480.
    DOI  |   Google Scholar
  18. Ramanah R, Berger MB, Parratte BM, DeLancey JO. Anatomy and histology of apical support: A literature review concerning cardinal and uterosacral ligaments. Int Urogynecol J. 2012; 23(11): 1483-1494.
    DOI  |   Google Scholar
  19. Kerkhof MH, Hendriks L, Brölmann HAM. Changes in connective tissue in patients with pelvic organ prolapse-a review of the current literature. Int Urogynecol J. 2009; 20(4): 461-474.
    DOI  |   Google Scholar
  20. Godwin AR, Singh M, Lockhart-Cairns MP, Alanazi YF, Cain SA, Baldock C. The role of fibrillin and microfibril binding proteins in elastin and elastic fibre assembly. Matrix Biol. 2019; 84: 17-30.
    DOI  |   Google Scholar
  21. Nakad B, Fares F, Azzam N, Feiner B, Zilberlicht A, Abramov Y. Estrogen receptor and laminin genetic polymorphism among women with pelvic organ prolapse. Taiwanese J Obstet Gynecol. 2017; 56(6): 750-754.
    DOI  |   Google Scholar


Most read articles by the same author(s)

1 2 3 4 > >>